BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29245276)

  • 1. Clinical and microbiological characteristics of vancomycin-resistant Enterococcus faecium bloodstream infection in Central Taiwan.
    Chen CH; Lin LC; Chang YJ; Chang CY
    Medicine (Baltimore); 2017 Dec; 96(49):e9000. PubMed ID: 29245276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mortality analysis of Enterococcus faecium bloodstream infection in central Taiwan].
    Chang-Hua C; Li-Chen L; Yu-Jun C; Chih-Yen C
    Rev Chilena Infectol; 2016 Aug; 33(4):395-402. PubMed ID: 27905623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
    Suzuki H; Hase R; Otsuka Y; Hosokawa N
    J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
    Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series.
    Giacobbe DR; Labate L; Tutino S; Baldi F; Russo C; Robba C; Ball L; Dettori S; Marchese A; Dentone C; Magnasco L; Crea F; Willison E; Briano F; Battaglini D; Patroniti N; Brunetti I; Pelosi P; Bassetti M
    Ann Med; 2021 Dec; 53(1):1779-1786. PubMed ID: 34637370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vancomycin resistance in Enterococcus faecium bloodstream infection on mortality: A retrospective analysis of nationwide surveillance data.
    Huh K; Chung DR; Ha YE; Ko JH; Huh HJ; Lee NY; Cho SY; Kang CI; Peck KR; Song JH;
    Int J Infect Dis; 2023 Sep; 134():8-14. PubMed ID: 37172775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting.
    Xie O; Slavin MA; Teh BW; Bajel A; Douglas AP; Worth LJ
    BMC Infect Dis; 2020 Mar; 20(1):228. PubMed ID: 32188401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
    Hayakawa K; Marchaim D; Martin ET; Tiwari N; Yousuf A; Sunkara B; Pulluru H; Kotra H; Hasan A; Bheemreddy S; Sheth P; Lee DW; Kamatam S; Bathina P; Nanjireddy P; Chalana IK; Patel S; Kumar S; Vahia A; Ku K; Yee V; Swan J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
    Antimicrob Agents Chemother; 2012 May; 56(5):2452-8. PubMed ID: 22354290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.
    Lu CL; Chuang YC; Chang HC; Chen YC; Wang JT; Chang SC
    J Antimicrob Chemother; 2012 Sep; 67(9):2243-9. PubMed ID: 22618861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
    Shukla BS; Shelburne S; Reyes K; Kamboj M; Lewis JD; Rincon SL; Reyes J; Carvajal LP; Panesso D; Sifri CD; Zervos MJ; Pamer EG; Tran TT; Adachi J; Munita JM; Hasbun R; Arias CA
    Clin Infect Dis; 2016 Jun; 62(12):1514-1520. PubMed ID: 27045126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
    Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
    Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: a two-year single-centre experience.
    Lupia T; Roberto G; Scaglione L; Shbaklo N; De Benedetto I; Scabini S; Mornese Pinna S; Curtoni A; Cavallo R; De Rosa FG; Corcione S
    Intern Emerg Med; 2022 Jun; 17(4):1129-1137. PubMed ID: 35092582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual increase of vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a university hospital in Taiwan.
    Chiang PC; Wu TL; Su JY; Huang YC; Chiu YP; Chia JH; Kuo AJ; Su LH
    Chang Gung Med J; 2007; 30(6):493-503. PubMed ID: 18350732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of Enterococcus faecium on Enterococcal bloodstream infections: a 14-year study in a Swiss tertiary hospital.
    Weisser M; Capaul S; Dangel M; Elzi L; Kuenzli E; Frei R; Widmer A
    Infect Control Hosp Epidemiol; 2013 Oct; 34(10):1109-12. PubMed ID: 24018931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
    Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
    Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of
    Kim D; Yoon EJ; Hong JS; Lee H; Shin KS; Shin JH; Kim YR; Kim HS; Kim YA; Uh Y; Shin JH; Park YS; Jeong SH
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
    Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.